Personal information

Verified email domains

Activities

Works (42)

Characterizing Prodrome (Premonitory Phase) in Migraine

Neurology Clinical Practice
2025-02 | Journal article
Contributors: Todd J. Schwedt; Richard B. Lipton; Peter J. Goadsby; Chia-Chun Chiang; Brad C. Klein; Cory Hussar; Chengcheng Liu; Sung Yun Yu; Michelle Finnegan; Joel M. Trugman
Source: check_circle
Crossref

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study

Headache: The Journal of Head and Face Pain
2025-02 | Journal article
Contributors: Elizabeth K. Seng; E. Jolanda Muenzel; Robert E. Shapiro; Dawn C. Buse; Michael L. Reed; Anthony J. Zagar; Sait Ashina; Susan Hutchinson; Robert A. Nicholson; Richard B. Lipton
Source: check_circle
Crossref

Symptoms across the phases of the migraine cycle from the patient's perspective: Results of the MiCOAS qualitative study

Headache: The Journal of Head and Face Pain
2025-02 | Journal article
Contributors: James S. McGinley; Rikki Mangrum; Maya T. Gerstein; Kelly P. McCarrier; Carrie R. Houts; Dawn C. Buse; Alexandra L. Bryant; R. J. Wirth; Richard B. Lipton
Source: check_circle
Crossref

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings

Headache: The Journal of Head and Face Pain
2025-01 | Journal article
Contributors: Fred Cohen; Caroline V. Brooks; Daniel Sun; Dawn C. Buse; Michael L. Reed; Kristina M. Fanning; Richard B. Lipton
Source: check_circle
Crossref

Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review

Headache: The Journal of Head and Face Pain
2025-01 | Journal article
Contributors: Richard B. Lipton; Astrid Gendolla; Lucy Abraham; Aaron Jenkins; Jersen Telfort; Karin Hygge Blakeman; Phillip A. Saccone; Iwona Pustulka; Iain Fotheringham; Anita Engh
Source: check_circle
Crossref

Early Improvements With Atogepant for the Preventive Treatment of Migraine

Neurology
2025-01-28 | Journal article
Contributors: Richard B. Lipton; Pranav Gandhi; Cristina Tassorelli; Uwe Reuter; Andrea M. Harriott; Dagny Holle-Lee; Christopher H. Gottschalk; Brian Neel; Yingyi Liu; Hua Guo et al.
Source: check_circle
Crossref

Sleep Disordered Breathing and Subsequent Neuroimaging Markers of Brain Health in Hispanic/Latino Adults

Neurology
2025-01-14 | Journal article
Contributors: Alberto R. Ramos; Christian Agudelo; Kevin A. Gonzalez; Wassim Tarraf; Martha Daviglus; Linda C. Gallo; Carmen I. Isasi; Sonya Kaur; Richard B. Lipton; Sanjay R. Patel et al.
Source: check_circle
Crossref

What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle

Neurology and Therapy
2024-12 | Journal article
Contributors: Richard B. Lipton; Jessica Ailani; Andrew M. Blumenfeld
Source: check_circle
Crossref

Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study

Headache: The Journal of Head and Face Pain
2024-11 | Journal article
Contributors: Elizabeth K. Seng; Mark J. Burish; Brenda T. Fenton; Emmanuelle A. D. Schindler; Bin Zhou; Manali A. Phadke; Melissa Skanderson; Rachel Best; Richard B. Lipton; Jason J. Sico
Source: check_circle
Crossref

Ubrogepant users' real‐world experience: Patients on ubrogepant, characteristics and outcomes (UNIVERSE) study

Headache: The Journal of Head and Face Pain
2024-11 | Journal article
Contributors: Anand R. Shewale; Weijie Poh; Michael L. Reed; Jinjie Liu; Francois Cadiou; Ali Ezzati; Kate Burslem; Shivaji Manthena; Richard B. Lipton
Source: check_circle
Crossref

Plain Language Summary Publication: Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study

Headache: The Journal of Head and Face Pain
2024-09 | Journal article
Contributors: Manjit Matharu; Zaza Katsarava; Dawn C. Buse; Katherine Sommer; Michael L. Reed; Kristina M. Fanning; Richard B. Lipton
Source: check_circle
Crossref

Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome

Neurology
2024-09-24 | Journal article
Contributors: Richard B. Lipton; Andrea M. Harriott; Julia Y. Ma; Jonathan H. Smith; Jonathan Stokes; Pranav Gandhi; Krutika Jariwala-Parikh; Gabriel S. Jensen; Joel M. Trugman; David W. Dodick
Source: check_circle
Crossref

Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study

Cephalalgia
2024-08 | Journal article
Contributors: Zaza Katsarava; Dawn C Buse; Elizabeth Leroux; Michel Lanteri-Minet; Fumihiko Sakai; Manjit S Matharu; Aubrey Manack Adams; Karen Carr; Kristina M Fanning; Richard B Lipton
Source: check_circle
Crossref

Long-term safety of zavegepant nasal spray for the acute treatment of migraine: A phase 2/3 open-label study

Cephalalgia
2024-08 | Journal article
Contributors: Kathleen Mullin; Robert Croop; Linda Mosher; Terence Fullerton; Jennifer Madonia; Richard B. Lipton
Source: check_circle
Crossref

Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO‐I) cross‐sectional study

Headache: The Journal of Head and Face Pain
2024-07 | Journal article
Contributors: Manjit Matharu; Zaza Katsarava; Dawn C. Buse; Katherine Sommer; Michael L. Reed; Kristina M. Fanning; Richard B. Lipton
Source: check_circle
Crossref

Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks

Headache: The Journal of Head and Face Pain
2024-07 | Journal article
Contributors: Richard B. Lipton; Jessica Ailani; Kathleen Mullin; Jelena M. Pavlovic; Stewart J. Tepper; David W. Dodick; Andrew M. Blumenfeld
Source: check_circle
Crossref

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials

Headache: The Journal of Head and Face Pain
2024-07 | Journal article
Contributors: Stephen D. Silberstein; Hans‐Christoph Diener; David W. Dodick; Katherine Sommer; Richard B. Lipton
Source: check_circle
Crossref

Post-Hoc Assessment of Cognitive Efficacy in Alzheimer’s Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial

Current Alzheimer Research
2024-05 | Journal article
Contributors: Nicolai D. Ayasse; Walter F. Stewart; Richard B. Lipton; David Gomez-Ulloa; M. Chris Runken
Source: check_circle
Crossref

A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine

Cephalalgia
2024-04 | Journal article
Contributors: Robert Croop; Gary Berman; David Kudrow; Kathleen Mullin; Alexandra Thiry; Meghan Lovegren; Gilbert L’Italien; Richard B Lipton
Source: check_circle
Crossref

A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults

Headache: The Journal of Head and Face Pain
2024-03 | Journal article
Contributors: Richard B. Lipton; Detlef Albrecht; Maria Bermudez; Jerry Hu; Elizabeth Hussey; Jeff Levy
Source: check_circle
Crossref

Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex

Cephalalgia
2024-03 | Journal article
Contributors: Frank Porreca; Edita Navratilova; Joe Hirman; Antoinette Maassen van den Brink; Richard B Lipton; David W Dodick
Source: check_circle
Crossref

Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury

Cephalalgia
2024-03 | Journal article
Contributors: Håkan Ashina; Hans-Christoph Diener; Cristina Tassorelli; Ann I. Scher; Richard B. Lipton; Patricia Pozo-Rosich; Alexandra J. Sinclair; Catherine D. Chong; Alan G. Finkel; Messoud Ashina et al.
Source: check_circle
Crossref

Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults

Cephalalgia
2024-02 | Journal article
Contributors: Robert Croop; Rajinder Bhardwaj; Matt S. Anderson; Kyle T. Matschke; Jennifer Hould; Richard Bertz; Jing Liu; Richard B. Lipton
Source: check_circle
Crossref

Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine

Cephalalgia
2024-02 | Journal article
Contributors: Anand R. Shewale; Jennifer A. Brandenburg; Kate Burslem; Richard B. Lipton; Jalpa A. Doshi
Source: check_circle
Crossref

International Classification of Headache Disorders-4 – Work in Progress 1

Cephalalgia
2024-02 | Journal article
Contributors: Peter J. Goadsby; Stefan Evers; Amy A. Gelfand; Richard B. Lipton; Arne May; Patricia Pozo-Rosich; Jean Schoenen; Todd J. Schwedt; Cristina Tassorelli; Gisela Terwindt et al.
Source: check_circle
Crossref

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine

Headache: The Journal of Head and Face Pain
2024-02 | Journal article
Contributors: Rikki Mangrum; Alexandra L. Bryant; Maya T. Gerstein; Kelly P. McCarrier; Carrie R. Houts; James S. McGinley; Dawn C. Buse; Richard B. Lipton; R. J. Wirth
Source: check_circle
Crossref

Risk factors for migraine disease progression: a narrative review for a patient-centered approach

Journal of Neurology
2023-12 | Journal article
Contributors: Richard B. Lipton; Dawn C. Buse; Stephanie J. Nahas; Gretchen E. Tietjen; Vincent T. Martin; Elin Löf; Thomas Brevig; Roger Cady; Hans-Christoph Diener
Source: check_circle
Crossref

Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial

Cephalalgia
2023-09 | Journal article
Contributors: Richard B. Lipton; Rashmi B. Halker Singh; Laszlo Mechtler; Jennifer McVige; Julia Ma; Sung Yun Yu; Jonathan Stokes; Brett Dabruzzo; Pranav Gandhi; Messoud Ashina
Source: check_circle
Crossref

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension

Cephalalgia
2023-08 | Journal article
Contributors: Susan P. Mollan; Clare L. Fraser; Kathleen B. Digre; Hans-Christoph Diener; Richard B. Lipton; Marianne Juhler; Neil R. Miller; Patricia Pozo-Rosich; Mansoureh Togha; Kristian Brock et al.
Source: check_circle
Crossref

Migraine screening in English and Spanish

Headache: The Journal of Head and Face Pain
2023-07 | Journal article
Contributors: Richard B. Lipton; Jason Sico; Elizabeth K. Seng
Source: check_circle
Crossref

Priority acute and preventive migraine treatment benefits: Results of the Migraine Clinical Outcome Assessment System (MiCOAS) qualitative study of people living with migraine

Headache: The Journal of Head and Face Pain
2023-07 | Journal article
Contributors: Rikki Mangrum; Maya T. Gerstein; Calvin J. Hall, III; Dawn C. Buse; Carrie R. Houts; James S. McGinley; Kelly P. McCarrier; Richard B. Lipton; R. J. Wirth
Source: check_circle
Crossref

Living in society, living with migraine: Editorial for the 2022 Members' Choice Award paper

Headache: The Journal of Head and Face Pain
2023-06 | Journal article
Contributors: Elizabeth K. Seng; Amanda Parker; Robert E. Shapiro; Dawn C. Buse; Matthew S. Robbins; Richard B. Lipton
Source: check_circle
Crossref

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305)

Advances in Therapy
2023-02 | Journal article
Contributors: Lauren C. Powell; Gilbert L’Italien; Evan Popoff; Karissa Johnston; Fiona O’Sullivan; Linda Harris; Robert Croop; Vladimir Coric; Richard B. Lipton
Source: check_circle
Crossref

Interrelationships of Sleep Quality, Obesity Severity, and Clinical Headache Features among Women with Comorbid Migraine and Obesity

Journal of Clinical Medicine
2023-02-22 | Journal article
Contributors: Leah M. Schumacher; Samantha G. Farris; J. Graham Thomas; Richard B. Lipton; Jelena Pavlovic; Angeliki Vgontzas; Dale S. Bond
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Medication overuse headache

Nature Reviews Disease Primers
2023-02-02 | Journal article
Contributors: Sait Ashina; Gisela M. Terwindt; Timothy J. Steiner; Mi Ji Lee; Frank Porreca; Cristina Tassorelli; Todd J. Schwedt; Rigmor H. Jensen; Hans-Christoph Diener; Richard B. Lipton
Source: check_circle
Crossref

Pain sensitivity in relation to frequency of migraine and tension-type headache with or without coexistent neck pain: an exploratory secondary analysis of the population study

Scandinavian Journal of Pain
2023-01-27 | Journal article
Contributors: Sait Ashina; Lars Bendtsen; Rami Burstein; Afrim Iljazi; Rigmor Hoejland Jensen; Richard B. Lipton
Source: check_circle
Crossref

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura

Journal of Pain Research
2021-08 | Journal article
Contributors: Richard B Lipton; Sagar Munjal; Stewart J Tepper; Charles Iaconangelo; Daniel Serrano
Source: check_circle
Crossref

Potassium channel openers — novel triggers of aura and migraine

Nature Reviews Neurology
2021-07-26 | Journal article
Contributors: Alan M. Rapoport; Richard B. Lipton
Source: check_circle
Crossref

Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome

Headache: The Journal of Head and Face Pain
2021-05 | Journal article
Contributors: Richard B. Lipton; David W. Dodick; Jessica Ailani; Lora McGill; Joe Hirman; Roger Cady
Source: check_circle
Crossref

Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study

Headache: The Journal of Head and Face Pain
2021-04 | Journal article
Contributors: Richard B. Lipton; Joshua M. Cohen; Maja Galic; Michael J. Seminerio; Paul P. Yeung; Ernesto Aycardi; Marcelo E. Bigal; Kristen Bibeau; Dawn C. Buse
Source: check_circle
Crossref

Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT‐6) Total and Item‐Specific Scores in Chronic Migraine

Headache: The Journal of Head and Face Pain
2020-10 | Journal article
Contributors: Carrie R. Houts; R. J. Wirth; James S. McGinley; Roger Cady; Richard B. Lipton
Source: check_circle
Crossref

Bidirectional Changes in Anisotropy Are Associated with Outcomes in Mild Traumatic Brain Injury

American Journal of Neuroradiology
2016-11 | Journal article
Contributors: S.B. Strauss; N. Kim; C.A. Branch; M.E. Kahn; M. Kim; R.B. Lipton; J.M. Provataris; H.F. Scholl; M.E. Zimmerman; M.L. Lipton
Source: check_circle
Crossref